An ISFET based translinear sensor for DNA methylation detection

Sensors and Actuators, B: Chemical

Volumn 161, Issue 1, 2012, Pages 156-162

  Kalofonou, Melpomeni ^a   Georgiou, Pantelis ^a   Ou, Chung Pei ^a   Toumazou, Christofer ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; DNA methylation; ISFETs; Ratiometric detection; Weak inversion

Indexed keywords

CANCER; DNA METHYLATION; ISFETS; RATIOMETRIC DETECTION; WEAK INVERSIONS;

ALKYLATION; DISEASES; GENES; METHYLATION;

DNA;

EID: 84856213063     PISSN: 09254005     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.snb.2011.09.089     Document Type: Article

References (30)

1. Bergveld P. Thirty years of isfetology - what happened in the past 30 years and what may happen in the next 30 years Sensors and Actuators B: Chemical 88 1 2003 1 20 (Pubitemid 35412494)
2. Bausells J., Carrabina J., Errachid A., and Merlos A. Ion-sensitive field-effect transistors fabricated in a commercial CMOS technology Sensors and Actuators B: Chemical 57 1-3 1999 56 62 (Pubitemid 30529534)
3. Shepherd L., and Toumazou C. Weak inversion ISFETs for ultra-low power biochemical sensing and real-time analysis Sensors and Actuators B: Chemical 107 1 2005 468 473 (Pubitemid 40655108)
4. Shepherd L., and Toumazou C. A biochemical translinear principle with weak inversion ISFETs IEEE Transactions on Circuits and Systems I: Regular Papers 52 12 2005 2614 2619 (Pubitemid 43000817)
5. Purushothaman S., Toumazou C., and Ou C. Protons and single nucleotide polymorphism detection: a simple use for the ion sensitive field effect transistor Sensors and Actuators B: Chemical 114 2 2006 964 968
6. Georgiou P., and Toumazou C. ISFET characteristics in cmos and their application to weak inversion operation Sensors and Actuators B: Chemical 143 1 2009 211 217
7. D. Garner, H. Bai, P. Georgiou, T. Constandinou, S. Reed, L. Shepherd, W. Wong, K. Lim, C. Toumazou, A multichannel DNA SoC for rapid point-of-care gene detection, in: Solid-State Circuits Conference Digest of Technical Papers (ISSCC), IEEE, 2010, pp. 492-493.
8. Juffali W., Georgiou P., and Toumazou C. ISFET based urea: creatinine translinear sensor Electronics Letters 46 11 2010 746 748
9. Esteller M. Epigenetics in cancer New England Journal of Medicine 358 11 2008 1148 1159
10. Jones P., and Baylin S. The epigenomics of cancer Cell 128 4 2007 683 692 (Pubitemid 46273572)
11. Jones P., and Baylin S. The fundamental role of epigenetic events in cancer Nature Reviews Genetics 3 6 2002 415 428 (Pubitemid 34587077)
12. Jones P. Overview of cancer epigenetics Seminars in Hematology, vol. 42 2005 Elsevier pp. S3-S8 (Pubitemid 40961866)
13. Sadikovic B., Al-Romaih K., Squire J., and Zielenska M. Cause and consequences of genetic and epigenetic alterations in human cancer Current Genomics 9 6 2008 394
14. Shukla S., Mirza S., Sharma G., Parshad R., Gupta S., and Ralhan R. Detection of rassf1a and rarbeta hypermethylation in serum DNA from breast cancer patients Epigenetics: Official Journal of the DNA Methylation Society 1 2 2006 88
15. Esteller M., Sanchez-Cespedes M., Rosell R., Sidransky D., Baylin S., and Herman J. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients Cancer Research 59 1 1999 67
16. Goessl C., Krause H., Muller M., Heicappell R., Schrader M., Sachsinger J., and Miller K. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids Cancer Research 60 21 2000 5941
17. Tan S., Ida H., Lau Q., Goh B., Chieng W., Loh M., and Ito Y. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3 Oncology Reports 18 5 2007 1225 1230
18. Wong I., Dennis Lo Y., Yeo W., Lau W., and Johnson P. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients Clinical Cancer Research 6 9 2000 3516
19. Board R., Knight L., Greystoke A., Blackhall F., Hughes A., Dive C., and Ranson M. DNA methylation in circulating tumour DNA as a biomarker for cancer Biomarker Insights 2 2007 307
20. Hodgson D., Wellings R., Orr M., McCormack R., Malone M., Board R., and Cantarini M. Circulating tumour-derived predictive biomarkers in oncology Drug Discovery Today 15 3-4 2010 98 101
21. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps Nature Reviews Genetics 8 4 2007 286 298 (Pubitemid 46439286)
22. Laird P. The power and the promise of DNA methylation markers Nature Reviews Cancer 3 4 2003 253 266 (Pubitemid 37328861)
23. Frommer M., McDonald L., Millar D., Collis C., Watt F., Grigg G., Molloy P., and Paul C. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands Proceedings of the National Academy of Sciences of the United States of America 89 5 1992 1827
24. Laird P. Principles and challenges of genome-wide DNA methylation analysis Nature Reviews Genetics 11 3 2010 191 203
25. Reviewed methylation database in cancer (online), available at: http://www.pubmeth.org/.
26. Cheung H., Lee T., Rennert O., and Chan W. DNA methylation of cancer genome Birth Defects Research Part C: Embryo Today: Reviews 87 4 2009 335 350
27. Martinoia S., and Massobrio G. A behavioral macromodel of the ISFET in spice Sensors and Actuators B: Chemical 62 3 2000 182 189
28. Georgiou P., and Toumazou C. CMOS-based programmable gate ISFET Electronics Letters 44 2008 1289
29. Andreou A., and Boahen K. Translinear circuits in subthreshold MOS Analog Integrated Circuits and Signal Processing 9 2 1996 141 166 (Pubitemid 126708257)
30. B. Gilbert, Current-mode circuits from a translinear viewpoint: a tutorial, Analogue IC Design: The Current-Mode Approach, 1990, pp. 11-91.